WEREWOLF THERAPEUTICS, INC. (HOWL) SEC News March 13, 2026, 17:11 UTC 2 0 comments New Form 3 - Werewolf Therapeutics, Inc. <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0000905148-26-001247 <b>Size:</b> 22 KB Comment Full text
HCA HEALTHCARE, INC. (HCA) SEC News March 13, 2026, 17:11 UTC 2 0 comments New Form DEF 14A - HCA Healthcare, Inc. <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001193125-26-106142 <b>Size:</b> 7 MB Comment Full text
BIOATLA, INC. (BCAB) SEC News March 13, 2026, 17:06 UTC 1 0 comments New Form 424B2 - BioAtla, Inc. <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001539497-26-000924 <b>Size:</b> 107 KB Comment Full text
NEKTAR THERAPEUTICS (NKTR) SEC News March 13, 2026, 17:04 UTC 2 1 comments 📋 Wilson Mark Andrew (Ex-Officer) plans to sell 79K shares of NEKTAR THERAPEUTICS (at $72.64 each, total $5.7M) Filed: Mar 13, 2026 | ID: 002286 Comment Full text
AN2 THERAPEUTICS, INC. (ANTX) SEC News March 13, 2026, 17:02 UTC 0 0 comments New Form SCHEDULE 13G - AN2 Therapeutics, Inc. <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001213900-26-027660 <b>Size:</b> 19 KB Comment Full text
NUTEX HEALTH INC. (NUTX) SEC News March 13, 2026, 17:02 UTC 0 0 comments New Form DEFA14A - Nutex Health Inc. <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001628280-26-017684 <b>Size:</b> 600 KB Comment Full text
ABBOTT LABORATORIES (ABT) SEC News March 13, 2026, 17:02 UTC 0 0 comments New Form ARS - ABBOTT LABORATORIES <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001308179-26-000066 <b>Size:</b> 13 MB Comment Full text
NUTEX HEALTH INC. (NUTX) SEC News March 13, 2026, 17:02 UTC 0 0 comments New Form DEF 14A - Nutex Health Inc. <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001628280-26-017681 <b>Size:</b> 2 MB Comment Full text
ABBOTT LABORATORIES (ABT) SEC News March 13, 2026, 17:01 UTC 0 0 comments New Form DEFA14A - ABBOTT LABORATORIES <b>Filed:</b> 2026-03-13 <b>AccNo:</b> 0001308179-26-000065 <b>Size:</b> 4 MB Comment Full text
SCILEX HOLDING CO (SCLX) SEC News March 13, 2026, 16:59 UTC 2 1 comments (19% Negative) SCILEX HOLDING CO (SCLX) Announces Clinical Trial Timeline Adjustment Comment Full text